Can microfluidics address biomanufacturing challenges in drug/gene/cell therapies?-Reference-Cited by-同舟云学术

Can microfluidics address biomanufacturing challenges in drug/gene/cell therapies?

Published:2016-03-08 Issue:2 Volume:3 Page:87-98
ISSN:2056-3418
Container-title:Regenerative Biomaterials
language:en
Short-container-title:Regen Biomater

Author:

Chan Hon Fai,Ma Siying,Leong Kam W.

Publisher

Oxford University Press (OUP)

Subject

Biomaterials

Link

http://academic.oup.com/rb/article-pdf/3/2/87/7444468/rbw009.pdf

Reference114 articles.

1. Cell-based therapy technology classifications and translational challenges

2. Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies

3. Crasto AM. Glybera – The Most Expensive Drug in the world & First Approved Gene Therapy in the West. All About Drug. (20 December 2015, date last accessed)

4. Effect of physical therapy on muscle strength, respiratory muscles and functional parameters in patients with intensive care unit-acquired weakness

5. Advanced materials and processing for drug delivery: The past and the future

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving toward autonomous manufacturing by accelerating hydrodynamic fabrication of microstructures using deep neural networks;Micro and Nano Engineering;2024-09

2. Role of Microfluidics in Drug Encapsulation for Point-of-care Diagnosis and Prognosis;Lab-on-a-chip Devices for Advanced Biomedicines;2024-08-14

3. Multiscale polymeric fibers for drug delivery and tissue engineering;Biomedical Technology;2024-03

4. Continuous microfluidic platform combining cell lysis and protein extraction for screening overall process conditions;Journal of Chemical Technology & Biotechnology;2023-12-08

5. Selective Targeting of the Novel CK-10 Nanoparticles to the MDA-MB-231 Breast Cancer Cells;Journal of Pharmaceutical Sciences;2021-12